K. Leśniewski-Kmak

发表

The Polish Cancer Anemia Survey (POLCAS): a retrospective multicenter study of 999 cases

C. Szczylik, E. Starosławska, M. Wojtukiewicz, 2009, International journal of hematology.

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial

W. Scheithauer, P. Johnston, L. Garrison, 2006, British Journal of Cancer.

Bone tissue as the site of action of oncological drugs

M. Litwiniuk, B. Radecka, K. Leśniewski-Kmak, 2011 .

Phase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptor

R. Kratzke, Priya Kumar, A. Dudek, 2009, British Journal of Cancer.

Irinotecan in chemotherapy of advanced colorectal cancer

K. Leśniewski-Kmak, 2006 .

Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

M. Socinski, K. O'Byrne, T. Ciuleanu, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin’s lymphoma patients—the Polish Lymphoma Research Group (PLRG) Observational Study

J. Zaucha, F. Fallanca, M. Kobylecka, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Short-term effects of anastrozole therapy on serum lipid profile in patients with breast cancer, previously treated with tamoxifen. Preliminary report*

D. Rachoń, J. Wojtacki, K. Leśniewski-Kmak, 2001 .

Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME study.

E. Smit, P. Schnabel, J. Aerts, 2015, Lung cancer.

High-dose chemotherapy of germ-cell tumors - is it the end of the road?

C. Szczylik, K. Leśniewski-Kmak, W. Pawlak, 2003 .

Diagnostics of Progressive Multifocal Leukoencephalopathy in A Patient With Concomitant Lymphoma Infiltration of Central Nervous System During R-chop Chemotherapy- A Case Presentation and Review of the Literature.

J. Zaucha, P. Grabarczyk, C. Tukaj, 2014 .

Clinical practice in febrile neutropenia risk assessment and granulocyte colony-stimulating factor primary prophylaxis of febrile neutropenia in Poland

K. Krzemieniecki, M. Wojtukiewicz, E. Kosno-Kruszewska, 2014, Contemporary oncology.

M. Socinski, K. O'Byrne, T. Ciuleanu, 2008 .

Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention--review of the literature.

J. Wojtacki, E. Lewicka-Nowak, K. Leśniewski-Kmak, 2000, Medical science monitor : international medical journal of experimental and clinical research.

Fotemustine in palliative treatment of metastatic cutaneous and ocular melanoma – clinical experience and preliminary results

C. Szczylik, K. Leśniewski-Kmak, P. Langiewicz, 2003 .

Immunology of renal cell carcinoma

K. Leśniewski-Kmak, P. Nurzyński, J. Zolnierek, 2007 .

MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study.

P. Mohanty, T. Hickish, L. Wyrwicz, 2017, The Lancet. Oncology.

Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial.

M. Provencio, J. Penrod, F. Franke, 2019, European journal of cancer.

Management of symptomatic ascites and post-operative lymphocysts with an easy-to-use, patient-controlled, vascular catheter.

M. Stukan, M. Wróblewska, M. Dudziak, 2015, Gynecologic oncology.

Phase II Trial of Neoadjuvant Therapy with Carboplatin, Gemcitabine plus Thalidomide for Stages IIB and III Non-small Cell Lung Cancer

T. Larson, R. Kratzke, K. Dragnev, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The role of PET for interim response assessment in patients with Hodgkin’s lymphoma

J. Zaucha, B. Małkowski, K. Leśniewski-Kmak, 2009 .

Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study.

E. Smit, P. Schnabel, J. Aerts, 2015, Lung cancer.

Quantitative Assessment of the Clavicle Radiostructure as a Tool for Estimation of the Osteopathic Effect of Breast Cancer Chemotherapy

C. Szczylik, K. Leśniewski-Kmak, K. Zieliński, 2002, Breast Cancer Research and Treatment.

Anastrozole therapy and lipid profile: an update

E. Nowicka, J. Wojtacki, K. Leśniewski-Kmak, 2004 .

Retrospective analysis of eff ectiveness and toleration of treatment with platinum derivative and pemetrexed in patients with advanced (stage IIIB and IV) non-small non-squamous cell lung cancer in a few oncology centers

B. Radecka, K. Leśniewski-Kmak, J. Korniluk, 2013 .

Early treatment intensification with escalated BEACOPP in patients with Hodgkins lymphoma not responding to ABVD therapy

J. Zaucha, M. Zalewska, B. Małkowski, 2014, Acta oncologica.